US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...
Kinvard Bio is one of the few companies seriously trying to change that. It started as a scientific spinout from the Andrew ...
The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous, remote, endovascular ...
But Sohonos has not lived up to its sales potential, despite being the only drug on the market, perhaps owing to relatively ...
Akiram Therapeutics, a Swedish clinical-stage biotech company specialising in molecular radiotherapy, and leading ...
MSD (known as Merck in the United States and Canada) and Moderna have announced positive phase 3 results for intismeran autogene, an mRNA-based individualised neoantigen therapy (INT) for melanoma, in ...
More than 20,000 biotechnology leaders gathered in San Diego for the 2026 BIO International Convention under the theme, ...
Palo Alto, CA-based biotech Network Bio launched today with $50 million in financing. It has also announced a collaboration ...
New analysis from the Tufts Center for the Study of Drug Development (CSDD) and Palo Alto, CA-based Medable shows that AI ...
A jury in a Boston court has put Takeda on the hook for damages of $885 million – and potentially almost $2.5 billion – after concluding the company unlawfully delayed generic competition to its ...
LEO Pharma is betting up to $435 million on a pill that could give people with an ultra-rare light sensitivity disorder a way ...
Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results